Closing the loop between patients and innovative cell and gene therapies
Cell and gene therapy is unlocking cures and treatments for some of the toughest medical conditions. Unfortunately, cost, complex production and safety concerns can separate these therapies from the patients who need them the most.
Lupagen imagines a world where these constraints no longer exist.
Our goal is to make cell and gene therapy production and delivery as simple and widely accessible as standard blood transfusion and dialysis procedures are today.
With Lupagen’s bedside cell processing technologies, biopharmaceutical innovators can radically lower cost, simplify production and develop safer, patient-friendly therapies.